Non-classical cannabinoids: cyclohexylphenol and adamantyl derivatives (CP-47,497)
Indole alkaloids: JWH series, AB-PINACA, ADB-FUBINACA, ADB-CHMINACA (most common current generation)
Each generation of compounds replaced by more potent analogs after regulatory scheduling
Third-generation compounds (5F-ADB, 5F-MDMB-PICA) are more potent and associated with higher lethality
Therapeutic Considerations
No specific antidote exists for SC toxicity
Naloxone does not reverse SC effects but should be given if opioid coingestant cannot be excluded
Flumazenil is not indicated and may precipitate seizures if benzodiazepines have been coinsumed
Treatment is entirely supportive and symptom-directed
Benzodiazepines are the therapeutic cornerstone: address agitation, seizures, hyperthermia, and rhabdomyolysis simultaneously
Evidence base for specific interventions
AHA 2023 Focused Update on Toxicological Cardiac Arrest: supports ECMO for refractory poisoning arrest
AHA 2025 Guidelines support standard ACLS with toxicological modifications
No randomized controlled trials for specific SC treatment: evidence from case series and expert consensus
ACEP Level C recommendation: supportive care with benzodiazepines for SC toxicity
Clinical Toxicology 2015 systematic review: benzodiazepines most commonly used and effective agent
Duration of toxicity and prognosis
Mild SC toxicity resolves within 4-8 hours; severe cases may persist 24-72 hours
ICU length of stay median 3-5 days in published case series (JAMA Network Open 2020)
SC-associated rhabdomyolysis and AKI may require weeks of recovery
Mortality in ICU-admitted patients estimated 5-10% in published series
Severe cardiac arrest or MODS carries highest mortality
Survivors of severe SC toxicity may have persistent cognitive or psychiatric sequelae
Patient Discharge Instructions
copy discharge instructions
Discharge instructions for Synthetic Cannabinoid Toxicity
What happened: You were treated in the emergency department for toxic effects from synthetic cannabinoids (also known as K2, Spice, or fake weed). These are man-made chemicals that are much stronger and more dangerous than natural marijuana.
Your symptoms are expected to improve over the next 24-48 hours.
You may feel tired, slightly confused, or have muscle aches for the next 1-2 days.
Medications prescribed
Take all medications as directed by your doctor.
Do not take any additional sedatives, alcohol, or drugs — these can interact dangerously with residual effects.
Activity and diet
Rest for 24-48 hours after discharge.
Drink plenty of water (at least 2-3 litres per day) to help flush your kidneys.
Avoid strenuous activity until follow-up.
Follow-up appointments
See your family doctor or urgent care within 48-72 hours.
Blood tests to recheck your kidneys and muscle enzyme levels in 24-48 hours if prescribed.
Psychiatry or addictions counselling referral if arranged.
Return to the emergency department immediately if you experience
Seizures or convulsions
Chest pain, fast or irregular heartbeat, or fainting
Dark, brown, or cola-coloured urine
Decreased urination or no urine output
Severe muscle pain, swelling, or firmness of any limb
Worsening confusion, hallucinations, or inability to think clearly
High fever (temperature above 38.5 degrees Celsius)
Thoughts of harming yourself or others
Yellowing of skin or eyes (jaundice)
Important safety information
Synthetic cannabinoids are NOT safe alternatives to marijuana — they are far more dangerous and unpredictable
Standard urine drug tests do NOT detect synthetic cannabinoids, but they are still illegal and harmful
Products vary from batch to batch — even the same brand can have very different chemicals
Addiction resources
SAMHSA National Helpline (United States): 1-800-662-4357 (free, confidential, 24/7)
Speak with your doctor about treatment for substance use disorder
References
Guidelines and key sources
AHA 2023 Focused Update on Cardiac Arrest and Life-Threatening Toxicity
Lavonas EJ, Akpunonu PD, Arens AM, et al. 2023 American Heart Association Focused Update. Circulation. 2023
Supports ECMO for refractory toxicological cardiac arrest
Standard ACLS modifications for toxin-mediated arrest
Cao D, Arens AM, Chow SL, et al. Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 AHA Guidelines. Circulation. 2025
Systematic reviews and cohort studies
Prete MM, Feitosa GTB, et al. Adverse Clinical Effects Associated With the Use of Synthetic Cannabinoids: A Systematic Review. Drug and Alcohol Dependence. 2025
Tait RJ, Caldicott D, Mountain D, et al. A Systematic Review of Adverse Events Arising From the Use of Synthetic Cannabinoids. Clinical Toxicology. 2015
Kourouni I, Mourad B, Khouli H, et al. Critical Illness Secondary to Synthetic Cannabinoid Ingestion. JAMA Network Open. 2020
Kuai D, Rivera Blanco LE, Krotulski A, et al. Health Risks of Emerging Drug Use in Correctional Facilities. JAMA Network Open. 2024
Shopan N, Scolnik D, Hassoun E, et al. Acute Intoxication Caused by Three Common Synthetic Cannabinoids. Am J Emergency Medicine. 2023
Cooper ZD. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. Current Psychiatry Reports. 2016
Gorelick DA. Cannabis-Related Disorders and Toxic Effects. New England Journal of Medicine. 2023
Armenian P, Darracq M, Gevorkyan J, et al. Intoxication From Novel Synthetic Cannabinoids AB-PINACA and ADB-PINACA. Neuropharmacology. 2018
Hermanns-Clausen M, Sommer M, Zschiesche A, et al. Acute Toxicity of ADB-CHMINACA Including PRES. British Journal of Clinical Pharmacology. 2026
Waters ML, Dargan PI, Yates C, et al. Clinical Effects of Cannabis vs Synthetic Cannabinoid Receptor Agonists: European Hospital Cohort. Clinical Toxicology. 2024
Cordeiro SK, Daro RC, Klein-Schwartz W, Kim HK. Evolution of SC Receptor Agonist Exposure in the United States 2010-2015. Addiction. 2018
ICD-10-CM: T40.7XXA — Poisoning by other synthetic narcotics/cannabinoids, initial encounter
SNOMED CT: 767023003 — Toxic effect of synthetic cannabinoid
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.